Kailera Therapeutics, Inc.
Support and Resistance Levels
Past performance
News About KLRA
All events for KLRA
All deals for KLRA
Financial Ratios
Financial Statements
KLRA vs Sector & Peers
About Kailera Therapeutics, Inc.
Kailera Therapeutics is a biopharmaceutical company currently advancing through its clinical development stage, dedicated to cultivating a varied portfolio of cutting-edge treatments. These therapeutics are specifically engineered to tackle obesity and its associated metabolic disorders. The company distinguishes itself through its focus on innovative methodologies, offering both injectable and orally administered formulations for sustainable weight management. Its most advanced candidate is a groundbreaking dual-action gut hormone receptor agonist, which has reported encouraging outcomes in its initial clinical investigations. Website kailera.com
Headquarters Waltham, MA, US